Cargando…

DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach

BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinct...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Marie, Liem, Natalia, Vaithilingam, Aparna, Lim, Pei Li, Sapari, Nur Sabrina, Elahi, Eiram, Mok, Zuan Yu, Cheng, Chee Leong, Yan, Benedict, Pang, Brendan, Salto-Tellez, Manuel, Yong, Wei Peng, Iacopetta, Barry, Soong, Richie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986689/
https://www.ncbi.nlm.nih.gov/pubmed/24674026
http://dx.doi.org/10.1186/1471-230X-14-55
_version_ 1782311755041472512
author Loh, Marie
Liem, Natalia
Vaithilingam, Aparna
Lim, Pei Li
Sapari, Nur Sabrina
Elahi, Eiram
Mok, Zuan Yu
Cheng, Chee Leong
Yan, Benedict
Pang, Brendan
Salto-Tellez, Manuel
Yong, Wei Peng
Iacopetta, Barry
Soong, Richie
author_facet Loh, Marie
Liem, Natalia
Vaithilingam, Aparna
Lim, Pei Li
Sapari, Nur Sabrina
Elahi, Eiram
Mok, Zuan Yu
Cheng, Chee Leong
Yan, Benedict
Pang, Brendan
Salto-Tellez, Manuel
Yong, Wei Peng
Iacopetta, Barry
Soong, Richie
author_sort Loh, Marie
collection PubMed
description BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinctive clinicopathological and molecular features. In contrast, the existence of a comparable CIMP subtype in gastric cancer (GC) has not been clearly established. To further investigate this issue, in the present study we performed comprehensive DNA methylation profiling of a well-characterised series of primary GC. METHODS: The methylation status of 1,421 autosomal CpG sites located within 768 cancer-related genes was investigated using the Illumina GoldenGate Methylation Panel I assay on DNA extracted from 60 gastric tumors and matched tumor-adjacent gastric tissue pairs. Methylation data was analysed using a recursively partitioned mixture model and investigated for associations with clinicopathological and molecular features including age, Helicobacter pylori status, tumor site, patient survival, microsatellite instability and BRAF and KRAS mutations. RESULTS: A total of 147 genes were differentially methylated between tumor and matched tumor-adjacent gastric tissue, with HOXA5 and hedgehog signalling being the top-ranked gene and signalling pathway, respectively. Unsupervised clustering of methylation data revealed the existence of 6 subgroups under two main clusters, referred to as L (low methylation; 28% of cases) and H (high methylation; 72%). Female patients were over-represented in the H tumor group compared to L group (36% vs 6%; P = 0.024), however no other significant differences in clinicopathological or molecular features were apparent. CpG sites that were hypermethylated in group H were more frequently located in CpG islands and marked for polycomb occupancy. CONCLUSIONS: High-throughput methylation analysis implicates genes involved in embryonic development and hedgehog signaling in gastric tumorigenesis. GC is comprised of two major methylation subtypes, with the highly methylated group showing some features consistent with a CpG island methylator phenotype.
format Online
Article
Text
id pubmed-3986689
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39866892014-04-16 DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach Loh, Marie Liem, Natalia Vaithilingam, Aparna Lim, Pei Li Sapari, Nur Sabrina Elahi, Eiram Mok, Zuan Yu Cheng, Chee Leong Yan, Benedict Pang, Brendan Salto-Tellez, Manuel Yong, Wei Peng Iacopetta, Barry Soong, Richie BMC Gastroenterol Research Article BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinctive clinicopathological and molecular features. In contrast, the existence of a comparable CIMP subtype in gastric cancer (GC) has not been clearly established. To further investigate this issue, in the present study we performed comprehensive DNA methylation profiling of a well-characterised series of primary GC. METHODS: The methylation status of 1,421 autosomal CpG sites located within 768 cancer-related genes was investigated using the Illumina GoldenGate Methylation Panel I assay on DNA extracted from 60 gastric tumors and matched tumor-adjacent gastric tissue pairs. Methylation data was analysed using a recursively partitioned mixture model and investigated for associations with clinicopathological and molecular features including age, Helicobacter pylori status, tumor site, patient survival, microsatellite instability and BRAF and KRAS mutations. RESULTS: A total of 147 genes were differentially methylated between tumor and matched tumor-adjacent gastric tissue, with HOXA5 and hedgehog signalling being the top-ranked gene and signalling pathway, respectively. Unsupervised clustering of methylation data revealed the existence of 6 subgroups under two main clusters, referred to as L (low methylation; 28% of cases) and H (high methylation; 72%). Female patients were over-represented in the H tumor group compared to L group (36% vs 6%; P = 0.024), however no other significant differences in clinicopathological or molecular features were apparent. CpG sites that were hypermethylated in group H were more frequently located in CpG islands and marked for polycomb occupancy. CONCLUSIONS: High-throughput methylation analysis implicates genes involved in embryonic development and hedgehog signaling in gastric tumorigenesis. GC is comprised of two major methylation subtypes, with the highly methylated group showing some features consistent with a CpG island methylator phenotype. BioMed Central 2014-03-28 /pmc/articles/PMC3986689/ /pubmed/24674026 http://dx.doi.org/10.1186/1471-230X-14-55 Text en Copyright © 2014 Loh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Loh, Marie
Liem, Natalia
Vaithilingam, Aparna
Lim, Pei Li
Sapari, Nur Sabrina
Elahi, Eiram
Mok, Zuan Yu
Cheng, Chee Leong
Yan, Benedict
Pang, Brendan
Salto-Tellez, Manuel
Yong, Wei Peng
Iacopetta, Barry
Soong, Richie
DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title_full DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title_fullStr DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title_full_unstemmed DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title_short DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
title_sort dna methylation subgroups and the cpg island methylator phenotype in gastric cancer: a comprehensive profiling approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986689/
https://www.ncbi.nlm.nih.gov/pubmed/24674026
http://dx.doi.org/10.1186/1471-230X-14-55
work_keys_str_mv AT lohmarie dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT liemnatalia dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT vaithilingamaparna dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT limpeili dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT saparinursabrina dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT elahieiram dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT mokzuanyu dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT chengcheeleong dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT yanbenedict dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT pangbrendan dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT saltotellezmanuel dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT yongweipeng dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT iacopettabarry dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach
AT soongrichie dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach